With a link between chronic health conditions and high spending, how can costs be lowered for patients, providers, and payers?
There is a close link between having persistently high spending and being diagnosed with certain chronic health conditions-such as HIV, multiple sclerosis, cystic fibrosis, rheumatoid arthritis, diabetes with complications, and a number of cancers, according to a new Kaiser Family Foundation (KFF) analysis.
“It’s no surprise there’s a correlation between chronic health conditions and high health spending,” says Peter Dunn of Activate Healthcare, provider of primary medical care services to employers and unions headquartered in Indianapolis. “As a provider of onsite health clinics for employers, we know that close and long-term relationships between patients and providers can have a dramatic impact on health outcomes and lower costs. But that’s only part of the solution. The healthcare industry, with help from the private sector, needs to continue to find ways to inspire individuals to take an active role in their health so they can better manage and prevent costly chronic conditions. Patient activation and convenient and accessible primary care are central to achieving a healthier population, and if done properly, savings will follow.”
KFF also found that in 2017 among people with three consecutive years of coverage from a large employer, 1.3% of enrollees accounted for 19.5% of overall health spending. Those in the top 5% of spending in each of the three years from 2015 to 2017-had average health spending of $87,870 in 2017. That compared to average per person spending of $5,870 among all large group enrollees during that period, according to the study.
Related article: How Artificial Intelligence Can Help Health Plans Manage Chronic Conditions
In addition, spending on retail prescription drugs accounted for almost 40% of spending for those with persistently high spending in 2017, more than twice the percentage for enrollees overall. People with persistently high spending averaged over $34,100 in spending on retail prescription drugs (not including rebates) in 2017, compared to $1,290 for enrollees overall, the analysis finds.
Addressing these recent healthcare spending trends, according to Jody Pigg, vice president at Quorum Health Resources, a healthcare professional services consulting company Brentwood, Tennessee, employee healthcare benefit programs continue to focus on the following:
“In the absence of programs as noted above at the employer level, individual plans in the general market/healthcare exchanges tend to move more ‘first dollar’ expenditures to the insured via increased annual deductibles and coinsurance requirements, creating disincentives for timely preventative screenings and routine primary care, while creating gaps in ‘first dollar payment ability’ and ‘dollars set aside to make those payments when needed’-moving the needle higher for bad debt recognition at the provider level,” Pigg says.
“In summary, better clinical outcomes at the most efficient cost levels are still a function of timely medical screenings, discounted at the local service level, with treatment protocols monitored by good case management discipline-with pricing a function of large-scale volume discounts created through large covered life pools,” he says.
This week on Tuning Into The C-Suite Briana Contreras spoke with Dr. Scott Hayworth, president and CEO of New York-based CareMount Medical. In this interview, the two discussed the importance of patients staying in contact with their doctors for the sake of reducing public health risks and to discuss ongoing care options with them.
Listen
Eric Levin talks PBMs and how Scripta is Tackling the Market's Challenges for Patients
July 22nd 2020MHE's Briana Contreras spoke with CEO of Scripta, Eric Levin. The two discussed the current state of the pharmacy benefit market and how the Scripta organization has been assisting its clients and their prescriptions prior to the COVID-19 pandemic and during.
Listen